Omada Health (NASDAQ:OMDA) Stock Price Down 9.3% – Here’s Why

Omada Health, Inc. (NASDAQ:OMDA) was down 9.3% on Friday . The company traded as low as $14.94 and last traded at $14.8730. Approximately 1,825,262 shares were traded during mid-day trading, an increase of 50% from the average daily volume of 1,218,513 shares. The stock had previously closed at $16.40.

Key Omada Health News

Here are the key news stories impacting Omada Health this week:

• Positive Sentiment: Multiple brokerages raised price targets or reiterated buy ratings (signals of analyst confidence and potential upside). Barclays raised its PT to $20 (overweight). Benzinga
• Positive Sentiment: Citizens Jmp raised its target to $21 (market outperform), implying meaningful upside from current levels. Benzinga
• Positive Sentiment: Needham reaffirmed a “buy” rating with a $28 target, the most bullish analyst view published today and supportive of a long?term growth narrative. Benzinga
• Positive Sentiment: Omada will serve as an independent program administrator in Eli Lilly’s Employer Connect program, expanding access for its GLP?1 Care Track — a strategic business development that could drive future revenue growth. GlobeNewswire
• Positive Sentiment: Q1 results: EPS of ($0.05) beat the Street ($0.08) and revenue was $78.05M — a modest beat that supports near?term execution credibility. Press Release / Slide Deck
• Neutral Sentiment: Wells Fargo nudged its target to $18 but kept an “equal weight” rating — a mixed signal that reduces the uniformity of bullish analyst views. Benzinga The Fly
• Neutral Sentiment: FY2026 revenue guidance was raised to $322–$330M versus a $319.1M consensus — a modest beat that supports revenue momentum but isn’t a large surprise. The company’s EPS guidance was not clearly specified in the release, which may leave some uncertainty around near?term profitability expectations. Slide Deck
• Neutral Sentiment: For detail and color on management comments, see the Q1 earnings call transcript and analyst metric breakdowns — useful for investors assessing guidance cadence and margin trajectory. Earnings Call Transcript Zacks analysis
• Negative Sentiment: Despite the positives, shares are trading lower with above?average volume — indicating short?term selling pressure or profit?taking. That suggests investors are weighing valuation, execution risks, or the lack of clearer EPS guidance. MarketBeat

Analysts Set New Price Targets

A number of brokerages have commented on OMDA. Morgan Stanley lowered their target price on Omada Health from $32.00 to $30.00 and set an “overweight” rating on the stock in a research note on Friday, March 6th. Wells Fargo & Company lifted their price target on Omada Health from $17.00 to $18.00 and gave the company an “equal weight” rating in a report on Friday. Barclays boosted their price target on Omada Health from $18.00 to $20.00 and gave the company an “overweight” rating in a research note on Friday. Evercore reaffirmed an “outperform” rating and set a $20.00 price objective on shares of Omada Health in a research report on Friday. Finally, Citizens Jmp boosted their target price on shares of Omada Health from $18.00 to $21.00 and gave the stock a “market outperform” rating in a research report on Friday. Ten equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $22.91.

Omada Health Stock Down 10.4%

The company has a market cap of $872.88 million and a price-to-earnings ratio of -86.34. The business has a 50-day simple moving average of $13.55 and a two-hundred day simple moving average of $15.85.

Omada Health (NASDAQ:OMDA) last issued its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. The company had revenue of $78.05 million for the quarter. As a group, equities analysts anticipate that Omada Health, Inc. will post -0.04 earnings per share for the current year.

Insider Buying and Selling at Omada Health

In related news, President Wei-Li Shao sold 2,829 shares of the company’s stock in a transaction on Wednesday, April 8th. The shares were sold at an average price of $12.71, for a total transaction of $35,956.59. Following the completion of the sale, the president directly owned 328,850 shares of the company’s stock, valued at approximately $4,179,683.50. This represents a 0.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sean P. Duffy sold 4,063 shares of the firm’s stock in a transaction on Monday, March 9th. The shares were sold at an average price of $14.34, for a total transaction of $58,263.42. Following the completion of the transaction, the chief executive officer owned 117,598 shares in the company, valued at $1,686,355.32. The trade was a 3.34% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 8,776 shares of company stock worth $120,483 over the last 90 days.

Hedge Funds Weigh In On Omada Health

A number of institutional investors have recently made changes to their positions in OMDA. Bank of New York Mellon Corp boosted its stake in Omada Health by 284.5% during the 1st quarter. Bank of New York Mellon Corp now owns 75,681 shares of the company’s stock valued at $951,000 after purchasing an additional 55,996 shares during the period. Fifth Third Bancorp acquired a new position in shares of Omada Health during the first quarter worth approximately $127,000. Inspire Investing LLC boosted its position in shares of Omada Health by 35.5% in the first quarter. Inspire Investing LLC now owns 40,462 shares of the company’s stock valued at $509,000 after acquiring an additional 10,591 shares during the period. SG Americas Securities LLC acquired a new stake in shares of Omada Health in the first quarter worth $10,401,000. Finally, XTX Topco Ltd acquired a new stake in shares of Omada Health in the fourth quarter worth $297,000.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.